Clinical Trials in San Antonio

Showing 9281-9300 of 14,633 trials

The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity

NCT03364335

This is a 24-week study to evaluate the effects of two fixed-dose combinations of leucine and sildenafil or two fixed-dose combinations of leucine, sildenafil and metformin compared to placebo. The primary objective of this study is to evaluate the percentage change in body weight in subjects from Baseline/Visit 2 (Day 1) to Study Termination/Visit 8 (Day 168/Week 24).

Obesity

NuSirt Biopharma267 participantsStarted Jan 2018

Mobile, Alabama, United States • Montclair, California, United States • Sacramento, California, United States +12 more locations

COMPLETEDPhase 3< 1 mile

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

NCT01603641

This study will evaluate the long-term safety of BOTOX® (botulinum toxin Type A) for the treatment of pediatric lower limb spasticity.

PediatricsMuscle SpasticityCerebral Palsy

Allergan370 participantsStarted Nov 2012

Pasadena, California, United States • Pomona, California, United States • San Diego, California, United States +53 more locations

The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

Find Trials by Condition in San Antonio

A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis

Increasing Physical Activity Among Mexican American Women (The Enlace Study)

Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder

Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Expanded Noninvasive Genomic Medical Assessment: The Enigma Study

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis

A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy

A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus

Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease

A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)

Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation